AU660153B2 - New medical use for a certain indole derivative and pharmaceutical composition containing it - Google Patents
New medical use for a certain indole derivative and pharmaceutical composition containing it Download PDFInfo
- Publication number
- AU660153B2 AU660153B2 AU86422/91A AU8642291A AU660153B2 AU 660153 B2 AU660153 B2 AU 660153B2 AU 86422/91 A AU86422/91 A AU 86422/91A AU 8642291 A AU8642291 A AU 8642291A AU 660153 B2 AU660153 B2 AU 660153B2
- Authority
- AU
- Australia
- Prior art keywords
- international
- headache
- pct
- document
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9022250 | 1990-10-12 | ||
| GB909022250A GB9022250D0 (en) | 1990-10-12 | 1990-10-12 | Medicaments |
| PCT/GB1991/001768 WO1992006688A1 (en) | 1990-10-12 | 1991-10-11 | New medical use for a certain indole derivative and pharmaceutical composition containing it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8642291A AU8642291A (en) | 1992-05-20 |
| AU660153B2 true AU660153B2 (en) | 1995-06-15 |
Family
ID=10683660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU86422/91A Ceased AU660153B2 (en) | 1990-10-12 | 1991-10-11 | New medical use for a certain indole derivative and pharmaceutical composition containing it |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5376672A (enExample) |
| EP (1) | EP0552205B1 (enExample) |
| JP (1) | JP3159263B2 (enExample) |
| KR (1) | KR0178762B1 (enExample) |
| AT (1) | ATE168006T1 (enExample) |
| AU (1) | AU660153B2 (enExample) |
| CA (1) | CA2093527A1 (enExample) |
| DE (1) | DE69129750T2 (enExample) |
| DK (1) | DK0552205T3 (enExample) |
| ES (1) | ES2118090T3 (enExample) |
| GB (1) | GB9022250D0 (enExample) |
| IE (1) | IE913580A1 (enExample) |
| IL (1) | IL99715A (enExample) |
| TW (1) | TW212756B (enExample) |
| WO (1) | WO1992006688A1 (enExample) |
| ZA (1) | ZA918117B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69434443T2 (de) * | 1993-12-28 | 2006-05-24 | Allergan, Inc., Irvine | Verwendung der neutrotoxischen Komponente des Botulinum Toxins zur Muskelschmerzbehandlung |
| DE69534341T2 (de) * | 1994-12-12 | 2006-05-24 | Omeros Corp., Seattle | Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und spasmen an einer wunde |
| US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
| US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
| WO2005123043A2 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| PL2124556T3 (pl) | 2006-10-09 | 2015-02-27 | Charleston Laboratories Inc | Kompozycje farmaceutyczne |
| CA3066426A1 (en) | 2008-01-09 | 2009-07-16 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
| US20100287502A1 (en) * | 2009-05-11 | 2010-11-11 | Olympus Imaging Corp. | Image search device and image search method |
| US8304179B2 (en) * | 2009-05-11 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for manufacturing a semiconductor device using a modified photosensitive layer |
| CA2767576C (en) | 2009-07-08 | 2020-03-10 | Charleston Laboratories Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
| CA3055170A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2162522A (en) * | 1984-08-01 | 1986-02-05 | Glaxo Group Ltd | An indole derivative |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GR79215B (enExample) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
-
1991
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active Expired - Fee Related
- 1991-10-11 EP EP91917473A patent/EP0552205B1/en not_active Expired - Lifetime
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en not_active Ceased
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2162522A (en) * | 1984-08-01 | 1986-02-05 | Glaxo Group Ltd | An indole derivative |
Also Published As
| Publication number | Publication date |
|---|---|
| AU8642291A (en) | 1992-05-20 |
| EP0552205A1 (en) | 1993-07-28 |
| JP3159263B2 (ja) | 2001-04-23 |
| ZA918117B (en) | 1992-08-26 |
| EP0552205B1 (en) | 1998-07-08 |
| IE913580A1 (en) | 1992-04-22 |
| US5376672A (en) | 1994-12-27 |
| IL99715A0 (en) | 1992-08-18 |
| CA2093527A1 (en) | 1992-04-13 |
| DE69129750D1 (de) | 1998-08-13 |
| KR0178762B1 (ko) | 1999-03-20 |
| ES2118090T3 (es) | 1998-09-16 |
| IL99715A (en) | 1996-01-19 |
| GB9022250D0 (en) | 1990-11-28 |
| WO1992006688A1 (en) | 1992-04-30 |
| ATE168006T1 (de) | 1998-07-15 |
| DK0552205T3 (da) | 1999-04-19 |
| JPH06501935A (ja) | 1994-03-03 |
| DE69129750T2 (de) | 1998-11-12 |
| TW212756B (enExample) | 1993-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6255334B1 (en) | 5HT 1 receptor agonists and metoclopramide for the treatment of migraine | |
| Chouinard et al. | Tryptophan‐nicotinamide, imipramine and their combination in depression: a controlled study | |
| AU660153B2 (en) | New medical use for a certain indole derivative and pharmaceutical composition containing it | |
| AU658155B2 (en) | Use of paroxetine for the treatment of senile dementia, or anorexia | |
| CA2053190C (en) | Preparation of medicaments for treating asthma using (s)-o-fluoromethyl-histidine and esters thereof | |
| Chase et al. | Parkinson's disease: Modification by 5‐hydroxytryptophan | |
| CA2025310A1 (en) | Methods of treating neurodegenerative conditions | |
| JPH08183735A (ja) | 不安症の治療 | |
| JP2000505104A (ja) | 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物 | |
| Bardsley et al. | Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease | |
| AU658169B2 (en) | Pharmaceutical composition containing granisetron and dexamethasone | |
| Dyson et al. | Interaction between choline theophyllinate and salmefamol in patients with reversible airways obstruction | |
| EP1099446B1 (en) | Combination for treating depression and anxiety containing a CNS-penetrant NK-1 receptor antagonist and an antidepressant or anxiolytic agent | |
| US5977121A (en) | Use of moxonidine for the treatment of atherosclerosis | |
| Clark et al. | Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease. | |
| JPH0232020A (ja) | モルフィン鎮痛治療における耐性発現の抑制方法および薬剤 | |
| Rosenberg et al. | Nikethamide, nicotinamide and some related compounds in anticholinesterase poisoning | |
| US4904673A (en) | Agent for treating bradycardia and bradyarrhythmia | |
| US5278164A (en) | Treatment of anxiety in benzodiazepine-withdrawn patients | |
| AU697290B2 (en) | Pharmaceuticals | |
| Brake et al. | Hemicholinium-3 (HC3) blocks the effects of ethylcholine mustard aziridinium (AF64A) in the developing rat | |
| Parrish | Cost-effectiveness of nebulised ipratropium as adjunctive therapy in acute asthma | |
| Rossoni et al. | Frusemide Inhalation Prevents Immunological Mediator Release and Respiratory Changes in Guinea-Pig | |
| Haglund et al. | An evaluation of the frequency of anti-inflammatory and analgesic drug intake among patients with acute gastrointestinal bleeding | |
| MXPA01004297A (en) | 5ht1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |